
|Articles|April 24, 2006
Accredo wins Flolan agreement
Accredo Health Group, a subsidiary of Medco, won a five-yearcontract as the sole specialty pharmacy for Flolan (epoprostenolsodium, Myogen) for pulmonary arterial hypertension (PAH). Terms ofthe deal were not announced.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Garzulys as Third Biosimilar to NovoLog
2
The ‘Vacation Peptide’ Raises New Alarms Across Pharmacy
3
One in 6 Deprescribed Medications Are Restarted Within 90 Days
4
Pregnant Women Favor Maternal RSV Vaccine Over Infant Antibody Shot
5

























